Verastem Inc

Explore how Verastem CEO Dan Paterson’s modest insider sales reflect his liquidity strategy, and what this means for investors amid positive clinical data and analyst optimism.

Verastem insider moves reveal a cautious optimism: executive option purchase hints at a near‑term rebound while routine sales signal liquidity, not panic.